비타민 B12 시장 예측(-2030년) : 제품 유형별, 형태별, 등급별, 판매 채널별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Vitamin B12 Market is accounted for $211.3 million in 2024 and is expected to reach $350.6 million by 2030 growing at a CAGR of 8.8% during the forecast period. Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a crucial role in various bodily functions. It is essential for the formation of red blood cells, maintenance of the nervous system, and DNA synthesis. Vitamin B12 is unique among vitamins because it contains the mineral cobalt, and its compounds are collectively referred to as cobalamins, which include active forms like methylcobalamin and 5-deoxyadenosylcobalamin, as well as inactive forms such as hydroxycobalamin and cyanocobalamin that convert into active forms in the body. Thus adequate intake through diet or supplementation is crucial, especially for at-risk populations.

According to the article published in Human Nutrition & Metabolism in March 2022, the prevalence of B12 deficiency in patients with chronic diseases such as type 2 diabetes was 17.5%.

Market Dynamics:

Driver:

Rising prevalence of vitamin B12 deficiency

As awareness of the health implications of vitamin B12 deficiency grows, more individuals are seeking supplements to prevent or address deficiencies. This is particularly true among at-risk populations, including the elderly, vegetarians, and those with gastrointestinal disorders that impair nutrient absorption. Healthcare professionals are increasingly recommending vitamin B12 supplements as part of standard treatment protocols, further boosting market demand

Restraint:

Limited natural sources

The growing dependency on fortified foods and supplements for vitamin B12 is due to limited natural sources, leading to market fluctuations and potential limitations in regions with less trusted options. Additionally, competition among manufacturers of vitamin B12 supplements and fortified foods creates increased marketing costs and pricing pressures, potentially affecting consumer trust and market stability hampering the market growth.

Opportunity:

Increase in vegan and vegetarian populations

The demand for vitamin B12 supplements is increasing due to the increasing number of vegans and vegetarians adopting plant-based diets. These diets are at a higher risk of deficiency, leading to a need for dietary supplements. Food manufacturers are expanding fortified food products, such as plant-based milks, cereals, and nutritional yeast, to meet the nutritional needs of these populations, contributing to market growth.

Threat:

Limited awareness in developing countries

Limited awareness about vitamin B12 deficiency can lead to underreporting of cases, causing insufficient public health initiatives and hindering market growth. This can result in companies hesitant to invest in marketing or product development for these populations. Additionally, inadequate health policies can result from governments not prioritizing micronutrient deficiencies, leading to a lack of food fortification initiatives and educational campaigns, further stunting market growth opportunities for vitamin B12 products.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the vitamin B12 market, leading to increased demand for supplements as consumers focus on boosting their immunity. Health experts and organizations have emphasized the importance of vitamins, including B12, in maintaining overall health during the crisis. This heightened awareness has driven sales of vitamin B12 products, with expectations for continued growth in the coming years.

The cyanocobalamin segment is expected to be the largest during the forecast period

The cyanocobalamin is expected to be the largest during the forecast period because cyanocobalamin is recognized as the most stable form of vitamin B12, which contributes to its dominant position in the market. Its stability allows for easier handling and longer shelf life compared to other forms of vitamin B12, such as methylcobalamin or adenosylcobalamin. This stability makes cyanocobalamin a preferred choice for manufacturers, as it can be produced, stored, and transported with less risk of degradation, thus ensuring consistent supply and availability

The dietary supplements segment is expected to have the highest CAGR during the forecast period

The dietary supplements segment is expected to have the highest CAGR during the forecast period owing to surge in demand for Vitamin B12 supplements due to their higher risk of deficiency. Technological advancements in supplement delivery, such as sublingual tablets, powders, and transdermal patches, have made it easier for consumers to incorporate Vitamin B12 into their daily routines.

Region with largest share:

North America is projected to hold the largest market share during the forecast period attributed to an increase in the use of dietary supplements, the advanced healthcare sector focusing on preventative care, and the availability of a wide range of products in the region. In addition, the growing prevalence of neural conditions and gastrointestinal issues is leading to an increased consumption of cobalamin supplements in the region.

Region with highest CAGR:

Asia Pacific is projected to witness the highest CAGR over the forecast period owing to the high prevalence of diabetic neuropathy, growth in the geriatric population, and rising awareness regarding health supplements are the factors anticipated to drive the region's growth. Moreover, the presence of key players and their growing production capacities are poised to significantly contribute to the region's market growth over projected years.

Key players in the market

Some of the key players in Vitamin B12 market include BASF SE , Adisseo, BTSA Biotechnologias Aplicadas S.L., Chem Kart India Pvt Ltd, DSM, Farbest Brands, Lonza Group, Merck KGaA, NOW Foods, NutraGenesis LLC, Nutrilo GmbH, Pfizer Inc, Pharmavit GmbH, Rabar Pty Ltd, Rousselot, Spectrum Chemical Manufacturing Corp., SternVitamin GmbH & Co. K.G., Thermo Fisher Scientifica and Zhejiang Shengda Bio-Pharm Co., Ltd.

Key Developments:

In July 2024, BASF has recently launched Haptex(R) 4.0, a next-generation polyurethane solution designed to revolutionize the production of sustainable synthetic leather. This innovative material is notable for being 100% recyclable, addressing long-standing challenges in the recycling of synthetic leather

In July 2024, Thermo Fisher Scientific has introduced a new pre-transplant risk assessment assay via its CLIA laboratory in Fishers, Ind., that helps assess risk of early acute rejection in kidney transplant recipients, providing data that may inform a more personalized approach to post-transplant immunosuppression management.

In June 2024, BASF and 'Pragati' extended full transparency & traceability to bio-based footwear solutions with SuCCESS code. It establishes a global standard for certifying castor oil and its derivatives, such as bio-based polyurethane, used in footwear manufacturing.

Product Types Covered:

• Fresh Trout
• Live Trout
• Frozen Trout
• Smoked Trout
• Canned Trout
• Other Product Types

Catch Types Covered:

• Aqua Cultured
• Wild Captured

Forms Covered:

• Whole
• Fillets
• Steaks
• Portions

Distribution Channels Covered:

• Direct Sales
• Online Retail
• Supermarkets/Hypermarkets
• Specialty Stores

End Users Covered:

• Households
• Restaurants
• Hotels
• Catering Services
• Food Processing
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Vitamin B12 Market, By Product Type

• 5.1 Introduction
• 5.2 Cyanocobalamin
• 5.3 Hydroxocobalamin
• 5.4 Methylcobalamin
• 5.5 Adenosylcobalamin

6 Global Vitamin B12 Market, By Form

• 6.1 Introduction
• 6.2 Tablets
• 6.3 Capsules
• 6.4 Powder
• 6.5 Injections
• 6.6 Sublingual
• 6.7 Gummies
• 6.8 Other Forms

7 Global Vitamin B12 Market, By Grade

• 7.1 Introduction
• 7.2 Pharmaceutical Grade
• 7.3 Food Grade
• 7.4 Feed Grade

8 Global Vitamin B12 Market, By Sales Channel

• 8.1 Introduction
• 8.2 Retail
• 8.3 Online
• 8.4 Wholesale

9 Global Vitamin B12 Market, By Application

• 9.1 Introduction
• 9.2 Dietary Supplements
• 9.3 Pharmaceuticals
• 9.4 Food & Beverages
• 9.5 Animal Feed
• 9.6 Other Applications

10 Global Vitamin B12 Market, By End User

• 10.1 Introduction
• 10.2 Healthcare Providers
• 10.3 Retail Consumers
• 10.4 Pharmacies & Drug Stores
• 10.5 Food Manufacturers
• 10.6 Other End Users

11 Global Vitamin B12 Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 BASF SE
• 13.2 Adisseo
• 13.3 BTSA Biotechnologias Aplicadas S.L.
• 13.4 Chem Kart India Pvt Ltd
• 13.5 DSM
• 13.6 Farbest Brands
• 13.7 Lonza Group
• 13.8 Merck KGaA
• 13.9 NOW Foods
• 13.10 NutraGenesis LLC
• 13.11 Nutrilo GmbH
• 13.12 Pfizer Inc
• 13.13 Pharmavit GmbH
• 13.14 Rabar Pty Ltd
• 13.15 Rousselot
• 13.16 Spectrum Chemical Manufacturing Corp.
• 13.17 SternVitamin GmbH & Co. K.G.
• 13.18 Thermo Fisher Scientific
• 13.19 Zhejiang Shengda Bio-Pharm Co., Ltd.